Page last updated: 2024-08-26

imipenem, anhydrous and Pneumonia, Staphylococcal

imipenem, anhydrous has been researched along with Pneumonia, Staphylococcal in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boulanger, BR; Fogarty, C; Fowler, C; Kahn, JB; Morgan, N; Oross, M; Tennenberg, A; West, M; Wiesinger, B; Wu, SC1
Fujita, Y; Fukabori, T; Mizobuchi, K; Nakamura, M; Takashina, R; Takizawa, H1
Abe, T; Domon, H; Fukuoka, T; Harasaki, T; Hirasawa, A; Ishii, C; Iwata, M; Kakuta, M; Kawada, H; Koga, T; Kubota, M; Kuwahara, S; Masuda, N; Ohya, S; Sakagawa, E; Takenouchi, T; Utsui, Y; Yasuda, H1
Horiguchi, S; Kusunoki, Y; Nagamatsu, I; Takase, A; Tateno, Y; Wagatsuma, Y1

Trials

2 trial(s) available for imipenem, anhydrous and Pneumonia, Staphylococcal

ArticleYear
Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study.
    Clinical therapeutics, 2003, Volume: 25, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Prospective Studies; Pseudomonas aeruginosa

2003
[Effect of imipenem/cilastatin combined with vancomycin for MRSA infection].
    The Japanese journal of antibiotics, 1997, Volume: 50, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Methicillin Resistance; Middle Aged; Pneumonia, Staphylococcal; Staphylococcal Infections; Urinary Tract Infections; Vancomycin

1997

Other Studies

2 other study(ies) available for imipenem, anhydrous and Pneumonia, Staphylococcal

ArticleYear
In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:12

    Topics: Administration, Oral; Animals; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier Proteins; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Drug Stability; Hexosyltransferases; Imipenem; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumonia, Staphylococcal; Prodrugs; Thienamycins

1997
[Clinical evaluation of imipenem/cilastatin sodium in children].
    The Japanese journal of antibiotics, 1986, Volume: 39, Issue:7

    Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cyclopropanes; Drug Combinations; Empyema; Female; Humans; Imipenem; Infant; Infusions, Intravenous; Kinetics; Male; Pneumonia, Staphylococcal; Pyelitis; Sepsis; Thienamycins; Tonsillitis

1986